Citation Impact
Citing Papers
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus
2013
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation
2016
Review article: the current management of acute liver failure
2009
An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation
2017
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Leishmaniasis
2018 Standout
The “ABC” of Virus-Specific T Cell Immunity in Solid Organ Transplantation
2015
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics
2009
Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada
2007
Viral Respiratory Tract Infections in Transplant Patients
2007
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Leishmaniasis in immunosuppressed individuals
2014
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Vaccination in Solid Organ Transplantation
2013
Emerging Infections of the Central Nervous System
2013
Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo
2013
The Immunology of Posttransplant CMV Infection
2016
Comparative Analysis of Assays for Detection of Cell-Mediated Immunity Toward Cytomegalovirus and M. tuberculosis in Samples From Deceased Organ Donors
2014
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
2011
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09
2012
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2014
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
2020
Severe Sepsis and Septic Shock
2013 Standout
Antiviral chemotherapeutic agents against respiratory viruses
2004
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs
2009
Antiviral agents active against influenza A viruses
2006
Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy
2004
Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case-Control Study
2007
The coming of age of de novo protein design
2016 StandoutNatureNobel
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020 Standout
Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in Humans
2014
Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy
2014
Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis
2014
Influenza virus-related critical illness: pathophysiology and epidemiology
2019
CMV: Prevention, Diagnosis and Therapy
2013
Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients
2013
Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis
2014
Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects
2013
Mechanisms of immunological tolerance
2015
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
2016
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
The Neuraminidase Inhibitor Oseltamivir Is Effective Against A/Anhui/1/2013 (H7N9) Influenza Virus in a Mouse Model of Acute Respiratory Distress Syndrome
2013
A Prospective Hospital‐Based Study of the Clinical Impact of Non–Severe Acute Respiratory Syndrome (Non‐SARS)–Related Human Coronavirus Infection
2006
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Antiviral combinations for severe influenza
2014
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients
2003
Cytomegalovirus in Solid Organ Transplantation
2013
Dancing with chemical formulae of antivirals: A panoramic view (Part 2)
2013
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Identification of a new human coronavirus
2004 Standout
Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
2019
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
2013
Emergence and pandemic potential of swine-origin H1N1 influenza virus
2009 Nature
Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients
2016
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
2016
CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients
2015
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial
2012
Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain Reaction
2005
An International Survey of Cytomegalovirus Management Practices in Lung Transplantation
2010
Respiratory viral infections within one year after pediatric lung transplant
2009
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study
2014
Influenza vaccination in solid-organ transplant recipients
2012
Cytomegalovirus in Solid Organ Transplant Recipients
2009
Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro
2003
An International Survey of Cytomegalovirus Prevention and Treatment Practices in Intestinal Transplantation
2013
Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients
2013
The use of antiviral agents for the management of severe influenza
2010
Outcomes of adults hospitalised with severe influenza
2010
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly
2018
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
The ABCs of Rhinoviruses, Wheezing, and Asthma
2010
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
2011
Treatment of cytomegalovirus infection and disease pre‐ and post‐quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?
2015
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients
2017
Prevention and Control of Seasonal Influenza with Vaccines
2016
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
2017
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
2013
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Colony Inhibition of Fibroblasts from Chimeric Dogs Mediated by the Dogs' Own Lymphocytes and Specifically Abrogated by Their Serum
1970 StandoutNobel
Antibody response to the non‐adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients
2012
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Adaptive strategies of the influenza virus polymerase for replication in humans
2009 StandoutNobel
Synergistic Combinations of Favipiravir and Oseltamivir Against Wild-Type Pandemic and Oseltamivir-Resistant Influenza A Virus Infections in Mice
2013
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
2018
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Update on Human Rhinovirus and Coronavirus Infections
2016
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
2018
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
2014
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
2017
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Potential role of CC chemokine receptor 6 in prediction of late‐onset cytomegalovirus infection following solid organ transplant
2015
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Changing Face of Vaccination in Immunocompromised Hosts
2014
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
2009
Works of Michael G. Ison being referenced
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
2020
A Survey of CMV Prevention Strategies After Liver Transplantation
2007
Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
2014
Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia
2003
Diagnosis, management and outcomes of adults hospitalized with influenza
2012
Current research on respiratory viral infections: Fourth International Symposium
2002
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
2012
Outcome of Influenza Infection Managed With Oseltamivir in Lung Transplant Recipients
2008
Comparative Activities of Oseltamivir and A‐322278 in Immunocompetent and Immunocompromised Murine Models of Influenza Virus Infection
2006
End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening Disease
2010
Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants
2015
Influenza, including the novel H1N1, in organ transplant patients
2010
Emerging Infections: Adenovirus Infections in Transplant Recipients
2006
Respiratory syncytial virus infection in adults
2019
Antivirals and resistance: influenza virus
2011
Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients
2009
Expanded infectious diseases screening program for Hispanic transplant candidates
2010
Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor-Derived Infections Consensus Conference Report
2012
Clinical use of approved influenza antivirals: therapy and prophylaxis
2012
Detection and Diagnosis of Herpes Simplex Virus Infection in Adults with Acute Liver Failure
2008
Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?
2002
Recovery of Drug‐Resistant Influenza Virus from Immunocompromised Patients: A Case Series
2006
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations
2011
Cardiac Findings during Uncomplicated Acute Influenza in Ambulatory Adults
2005
Prevention and Treatment of Cancer-Related Infections
2012
Respiratory viral infections in transplant recipients
2005
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
2018
Ganciclovir‐resistant cytomegalovirus infection in solid organ transplant recipients: a single‐center retrospective cohort study
2016
Safety and Efficacy of Nebulized Zanamivir in Hospitalized Patients with Serious Influenza
2003
Prevention and Early Treatment of Opportunistic Viral Infections in Patients With Leukemia and Allogeneic Stem Cell Transplantation Recipients
2008
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
2019
Invasive Infections with Community-Associated Methicillin-Resistant Staphylococcus aureus after Kidney Transplantation
2008
Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital
2014
Current practices for treatment of respiratory syncytial virus and other non‐influenza respiratory viruses in high‐risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
2016
Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature.
2008
Safety and efficacy of foscarnet for the management of ganciclovir‐resistant or refractory cytomegalovirus infections: A single‐center study
2018